Browse by UCL Departments and Centres
Group by: Author | Type
Number of items: 93.
A
Alahmadi, AAS;
(2018)
Advancing our understanding of brain anatomy and function using MRI in healthy subjects and neurological diseases.
Doctoral thesis (Ph.D), UCL (University College London).
|
Amiri, H;
de Sitter, A;
Bendfeldt, K;
Battaglini, M;
Gandini Wheeler-Kingshott, CAM;
Calabrese, M;
Geurts, JJG;
... Vrenken, H; + view all
(2018)
Urgent challenges in quantification and interpretation of brain grey matter atrophy in individual MS patients using MRI.
NeuroImage: Clinical
, 19
pp. 466-475.
10.1016/j.nicl.2018.04.023.
|
Arrambide, G;
Rovira, A;
Sastre-Garriga, J;
Tur, C;
Castillo, J;
Rio, J;
Vidal-Jordana, A;
... Tintore, M; + view all
(2018)
Spinal cord lesions: A modest contributor to diagnosis in clinically isolated syndromes but a relevant prognostic factor.
Multiple Sclerosis Journal
, 24
(3)
pp. 301-312.
10.1177/1352458517697830.
|
B
Battiston, M;
Grussu, F;
Ianus, A;
Schneider, T;
Prados, F;
Fairney, J;
Ourselin, S;
... Samson, R; + view all
(2018)
An optimized framework for quantitative Magnetization Transfer imaging of the cervical spinal cord in vivo.
Magnetic Resonance in Medicine
, 79
(5)
pp. 2576-2588.
10.1002/mrm.26909.
|
Battiston, M;
Grussu, F;
Schneider, T;
Prados Carrasco, F;
Ourselin, S;
Wheeler-Kingshott, CAM;
Samson, R;
(2018)
Acceleration strategies for whole brain quantitative magnetization transfer imaging.
Presented at: ISMRM 2018, Paris, France.
|
Battiston, M;
Schneider, T;
Grussu, F;
Schenk, GJ;
Wergeland, S;
Tachrount, M;
Yiannakas, M;
... Samson, R; + view all
(2018)
Are we seeing any better? A comprehensive comparison of myelin biomarkers in the healthy and multiple sclerosis post mortem spinal cord.
In:
Proceedings of the Joint Annual Meeting ISMRM-ESMRMB 2018.
ISMRM: Paris, France.
|
Battiston, Marco;
(2018)
Quantitative MRI for measuring myelin content in human spinal cord.
Doctoral thesis (Ph.D), UCL (University College London).
|
Bichuetti, DB;
Franco, CA;
Elias, I;
Mendonca, ACR;
Diniz Carvalho, LF;
Diniz, DS;
Tur, C;
... Lobato de Oliveira, EM; + view all
(2018)
Multiple sclerosis risk perception and acceptance for Brazilian patients.
Arquivos de Neuro-Psiquiatria
, 76
(1)
pp. 6-12.
10.1590/0004-282X20170167.
|
Brown, R;
Benveniste, H;
Black, SE;
Charpak, S;
Dichgans, M;
Joutel, A;
Nedergaard, M;
... Wardlaw, JM; + view all
(2018)
Understanding the role of the perivascular space in cerebral small vessel disease.
Cardiovascular Research
10.1093/cvr/cvy113.
(In press).
|
Brownlee, WJ;
(2018)
Do spinal cord lesions matter in patients with clinically isolated syndrome and early MS?
[Editorial comment].
Multiple Sclerosis Journal
, 24
(4)
pp. 430-431.
10.1177/1352458517749048.
|
Brownlee, WJ;
(2018)
Misdiagnosis of multiple sclerosis: If you have a hammer, everything looks like a nail?
Neurology
10.1212/WNL.0000000000006584.
(In press).
|
Brownlee, WJ;
(2018)
Use (and misuse) of the McDonald criteria to diagnose multiple sclerosis.
[Editorial comment].
European Journal of Neurology
, 25
(2)
pp. 209-210.
10.1111/ene.13501.
|
Brownlee, WJ;
Miszkiel, KA;
Tur, C;
Barkhof, F;
Miller, DH;
Ciccarelli, O;
(2018)
Inclusion of optic nerve involvement in dissemination in space criteria for multiple sclerosis.
Neurology
, 91
(12)
e1130-e1134.
10.1212/WNL.0000000000006207.
|
C
Casiraghi, L;
Alahmadi, A;
Monteverdi, A;
Palesi, F;
Castellazzi, G;
Savini, G;
Friston, K;
... D'Angelo, E; + view all
(2018)
Force-related BOLD effects during naturalistic and symbolic effort observation.
Presented at: ISMRM 2018, Paris, France.
|
Castellazzi, G;
Bruno, SD;
Toosy, AT;
Casiraghi, L;
Palesi, F;
Savini, G;
D'Angelo, E;
(2018)
Prominent changes in cerebro-cerebellar functional connectivity during continuous cognitive processing.
Frontiers in Cellular Neuroscience
, 12
, Article 331. 10.3389/fncel.2018.00331.
|
Castellazzi, G;
Debernard, L;
Melzer, TR;
Dalrymple-Alford, JC;
D'Angelo, E;
Miller, DH;
Wheeler-Kingshott, CAM;
(2018)
Functional connectivity alternations reveal complex mechanisms based on clinical and radiological status in mild relapsing remitting multiple sclerosis.
Frontiers in Neurology
, 9
, Article 690. 10.3389/fneur.2018.00690.
|
Caverzasi, E;
Mandelli, ML;
Hoeft, F;
Watson, C;
Meyer, M;
Allen, IE;
Papinutto, N;
... Gorno-Tempini, ML; + view all
(2018)
Abnormal age-related cortical folding and neurite morphology in children with developmental dyslexia.
NeuroImage: Clinical
, 18
pp. 814-821.
10.1016/j.nicl.2018.03.012.
|
Charalambous, T;
Prados Carrasco, F;
Tur Gomez, C;
Kanber, B;
Ourselin, S;
Chard, D;
Clayden, JD;
... Toosy, A; + view all
(2018)
Longitudinal Analysis Framework of DWI Data for Reconstructing Structural Brain Networks with Application to Multiple Sclerosis.
In: Kaden, E and Grussu, F and Ning, L and Tax, CMW and Veraart, J, (eds.)
Computational Diffusion MRI.
(pp. pp. 205-218).
Springer: Cham, Switzerland.
|
Ciccarelli, O;
De Stefano, N;
Giorgio, A;
Tintoré, M;
Amato, MP;
Kappos, L;
Palace, J;
... Rovira, A; + view all
(2018)
Radiologically isolated syndrome or subclinical multiple sclerosis: MAGNIMS consensus recommendations.
Multiple Sclerosis Journal
, 24
(2)
pp. 214-221.
10.1177/1352458517717808.
|
Connick, P;
De Angelis, F;
Parker, RA;
Plantone, D;
Doshi, A;
John, N;
Stutters, J;
... UK Multiple Sclerosis Society Clinical Trials Network; + view all
(2018)
Multiple Sclerosis-Secondary Progressive Multi-Arm Randomisation Trial (MS-SMART): a multiarm phase IIb randomised, double-blind, placebo-controlled clinical trial comparing the efficacy of three neuroprotective drugs in secondary progressive multiple sclerosis.
BMJ Open
, 8
, Article e021944. 10.1136/bmjopen-2018-021944.
|
Cortese, R;
Ciccarelli, O;
(2018)
Clinical monitoring of multiple sclerosis should routinely include spinal cord imaging - Yes.
Multiple Sclerosis Journal
, 24
(12)
pp. 1536-1537.
10.1177/1352458518778010.
|
Cortese, R;
Magnollay, L;
Tur Gomez, C;
Abdel-Aziz, K;
Jacob, A;
De Angelis, F;
Yiannakas, MC;
... Ciccarelli, O; + view all
(2018)
The value of the central vein sign at 3T to differentiate MS from seropositive-NMOSD.
Neurology
, 90
(14)
e1183-e1190.
10.1212/WNL.0000000000005256.
|
D
De Angelis, F;
John, NA;
Brownlee, WJ;
(2018)
Disease-modifying therapies for multiple sclerosis.
The BMJ
, 363
, Article k4674. 10.1136/bmj.k4674.
|
De Angelis, F;
Plantone, D;
Chataway, J;
(2018)
Pharmacotherapy in Secondary Progressive Multiple Sclerosis: An Overview.
CNS Drugs
, 32
(6)
pp. 499-526.
10.1007/s40263-018-0538-0.
|
Duignan, S;
Wright, S;
Rossor, T;
Cazabon, J;
Gilmour, K;
Ciccarelli, O;
Wassmer, E;
... Hacohen, Y; + view all
(2018)
Myelin oligodendrocyte glycoprotein and aquaporin‐4 antibodies are highly specific in children with acquired demyelinating syndromes.
Developmental Medicine and Child Neurology
, 60
(9)
pp. 958-962.
10.1111/dmcn.13703.
|
E
Eshaghi, A;
Marinescu, RV;
Young, AL;
Firth, NC;
Prados Carrasco, F;
Cardoso, MJ;
Tur Gomez, C;
... MAGNIMS Study Group, .; + view all
(2018)
Progression of regional grey matter atrophy in multiple sclerosis.
Brain
, 141
(6)
pp. 1665-1677.
10.1093/brain/awy088.
|
Eshaghi, A;
Prados Carrasco, F;
Brownlee, W;
Altmann, DR;
Tur Gomez, C;
Cardoso, MJ;
de Angelis, F;
... Ciccarelli, O; + view all
(2018)
Deep grey matter volume loss drives disability worsening in multiple sclerosis.
Annals of Neurology
, 83
(2)
pp. 210-222.
10.1002/ana.25145.
|
Eyre, M;
Hacohen, Y;
Barton, C;
Hemingway, C;
Lim, M;
(2018)
Therapeutic plasma exchange in paediatric neurology: a critical review and proposed treatment algorithm.
Developmental Medicine & Child Neurology
, 60
(8)
pp. 765-779.
10.1111/dmcn.13925.
|
Eyre, M;
Hameed, A;
Wright, S;
Brownlee, W;
Ciccarelli, O;
Bowman, R;
Lim, M;
... Hacohen, Y; + view all
(2018)
Retinal nerve fibre layer thinning is associated with worse visual outcome after optic neuritis in children with a relapsing demyelinating syndrome.
Developmental Medicine and Child Neurology
, 60
(12)
10.1111/dmcn.13757.
|
F
Filippi, M;
Preziosa, P;
Meani, A;
Ciccarelli, O;
Mesaros, S;
Rovira, A;
Frederiksen, J;
... Rocca, MA; + view all
(2018)
Prediction of a multiple sclerosis diagnosis in patients with clinically isolated syndrome using the 2016 MAGNIMS and 2010 McDonald criteria: a retrospective study.
The Lancet Neurology
, 17
(2)
10.1016/S1474-4422(17)30469-6.
|
G
Garcia-Reitboeck, P;
Phillips, A;
Piers, TM;
Villegas-Llerena, C;
Butler, M;
Mallach, A;
Rodrigues, C;
... Pocock, JM; + view all
(2018)
Human Induced Pluripotent Stem Cell-Derived Microglia-Like Cells Harboring TREM2 Missense Mutations Show Specific Deficits in Phagocytosis.
Cell Reports
, 24
(9)
pp. 2300-2311.
10.1016/j.celrep.2018.07.094.
|
Geraldes, R;
Ciccarelli, O;
Barkhof, F;
De Stefano, N;
Enzinger, C;
Filippi, M;
Hofer, M;
... MAGNIMS study group; + view all
(2018)
The current role of MRI in differentiating multiple sclerosis from its imaging mimics.
[Review].
Nat Rev Neurol
, 14
pp. 199-213.
10.1038/nrneurol.2018.14.
|
Giannoni, L;
Lange, F;
Davies, AL;
Dua, A;
Gustavson, B;
Smith, KJ;
Tachtsidis, I;
(2018)
Hyperspectral Imaging of the Hemodynamic and Metabolic States of the Exposed Cortex: Investigating a Commercial Snapshot Solution.
Advances in Experimental Medicine and Biology
, 1072
pp. 13-20.
10.1007/978-3-319-91287-5_3.
|
Gold, J;
Marta, M;
Meier, UC;
Christensen, T;
Miller, D;
Altmann, D;
Holden, D;
... Giovannoni, G; + view all
(2018)
A phase II baseline versus treatment study to determine the efficacy of raltegravir (Isentress) in preventing progression of relapsing remitting multiple sclerosis as determined by gadolinium-enhanced MRI: The INSPIRE study.
Multiple Sclerosis and Related Disorders
, 24
pp. 123-128.
10.1016/j.msard.2018.06.002.
|
Grussu, F;
Ianus, A;
Tur Gomez, C;
Prados Carrasco, F;
Schneider, T;
Kaden, E;
Ourselin, S;
... Wheeler-Kingshott, C; + view all
(2018)
Relevance of time-dependence for clinically viable diffusion imaging of the spinal cord.
Magnetic Resonance in Medicine
10.1002/mrm.27463.
|
H
Hacohen, Y;
Brownlee, WJ;
(2018)
Clinical commentary on 'Late-onset neutropenia and neurological relapse during long-term rituximab therapy in MOG antibody spectrum disorder'.
Multiple Sclerosis Journal
, 24
(12)
p. 1648.
10.1177/1352458518775245.
|
Hacohen, Y;
Messina, S;
Gan, H-W;
Wright, S;
Chandratre, S;
Leite, MI;
Fallon, P;
... Hemingway, C; + view all
(2018)
Endocrinopathies in paediatric-onset neuromyelitis optica spectrum disorder with aquaporin 4 (AQP4) antibody.
Multiple Sclerosis Journal
, 24
(5)
pp. 679-684.
10.1177/1352458517726593.
|
Hacohen, Y;
Palace, J;
(2018)
Time to separate MOG-Ab-associated disease from AQP4-Ab-positive neuromyelitis optica spectrum disorder.
Neurology
, 90
(21)
pp. 947-948.
10.1212/WNL.0000000000005619.
|
Hacohen, Y;
Rossor, T;
Mankad, K;
Chong, K;
Lux, A;
Wassmer, E;
Lim, M;
... Hemingway, C; + view all
(2018)
'Leukodystrophy‐like' phenotype in children with myelin oligodendrocyte glycoprotein antibody‐associated disease.
Developmental Medicine and Child Neurology
, 60
(4)
pp. 417-423.
10.1111/dmcn.13649.
|
Hacohen, Y;
Vincent, A;
(2018)
Autoimmune neurological disorders-does the age matter?
European Journal of Paediatric Neurology
, 22
(3)
pp. 341-343.
10.1016/j.ejpn.2018.01.025.
|
Hacohen, Y;
Wong, YY;
Lechner, C;
Jurynczyk, M;
Wright, S;
Konuskan, B;
Kalser, J;
... Lim, M; + view all
(2018)
Disease Course and Treatment Responses in Children With Relapsing Myelin Oligodendrocyte Glycoprotein Antibody–Associated Disease.
JAMA Neurology
, 75
(4)
pp. 478-487.
10.1001/jamaneurol.2017.4601.
|
Hagens, MHJ;
Burggraaff, J;
Kilsdonk, ID;
de Vos, ML;
Cawley, N;
Sbardella, E;
Andelova, M;
... MAGNIMS Study Group; + view all
(2018)
Three-Tesla MRI does not improve the diagnosis of multiple sclerosis: A multicenter study.
Neurology
, 91
(3)
10.1212/WNL.0000000000005825.
|
Hill, I;
Palombo, M;
Santin, MD;
Branzoli, F;
Philippe, A-C;
Wassermann, D;
Aigrot, M-S;
... Drobnjak, I; + view all
(2018)
Deep neural network based framework for in-vivo axonal permeability estimation.
In: Miller, KL and Port, JD, (eds.)
Proceedings of the Joint Annual Meeting ISMRM-ESMRMB 2018.
ISMRM (International Society for Magnetic Resonance in Medicine): Concord, CA, USA.
|
Horsburgh, K;
Wardlaw, JM;
van Agtmael, T;
Allan, SM;
Ashford, MLJ;
Bath, PM;
Brown, R;
... Work, LM; + view all
(2018)
Small vessels, dementia and chronic diseases – molecular mechanisms and pathophysiology.
Clinical Science
, 132
(8)
pp. 851-868.
10.1042/CS20171620.
|
I
Ismayilova, N;
Hacohen, Y;
MacKinnon, AD;
Elmslie, F;
Clarke, A;
(2018)
GLUT-1 deficiency presenting with seizures and reversible leukoencephalopathy on MRI imaging.
European Journal of Paediatric Neurology
, 22
(6)
pp. 1161-1164.
10.1016/j.ejpn.2018.02.002.
|
J
Joel, Z;
Izquierdo, P;
Liu, W;
Hall, C;
Roberts, M;
Yap, K;
Nick, A;
... Edwards, F; + view all
(2018)
A TauP301L mouse model of dementia; development of pathology, synaptic transmission, microglial response and cognition throughout life.
BioRxiv: Cold Spring Harbor, NY, USA.
|
Jung, J;
Eggleton, P;
Robinson, A;
Wang, J;
Gutowski, N;
Holley, J;
Newcombe, J;
... Michalak, M; + view all
(2018)
Calnexin is necessary for T cell transmigration into the central nervous system.
JCI Insight
, 3
(5)
, Article e98410. 10.1172/jci.insight.98410.
|
L
Lange, J;
Haslett, LJ;
Lloyd-Evans, E;
Pocock, JM;
Sands, MS;
Williams, BP;
Cooper, JD;
(2018)
Compromised astrocyte function and survival negatively impact neurons in infantile neuronal ceroid lipofuscinosis.
Acta Neuropathologica Communications
, 6
, Article 74. 10.1186/s40478-018-0575-4.
|
Liu, W;
Taso, O;
Wang, R;
Garcia-Reitboeck, P;
Andrews, WD;
Piers, TM;
Pocock, JM;
... Salih, D; + view all
(2018)
Trem2 promotes anti-inflammatory responses in microglia and is suppressed under pro-inflammatory conditions.
bioRxiv
|
Luisier, R;
Tyzack, GE;
Hall, CE;
Mitchell, JS;
Devine, H;
Taha, DM;
Malik, B;
... Patani, R; + view all
(2018)
Intron retention and nuclear loss of SFPQ are molecular hallmarks of ALS.
Nature Communications
, 9
, Article 2010. 10.1038/s41467-018-04373-8.
|
M
Marshall, I;
Thrippleton, MJ;
Bastin, ME;
Mollison, D;
Dickie, DA;
Chappell, FM;
Semple, SIK;
... Chandran, S; + view all
(2018)
Characterisation of tissue-type metabolic content in secondary progressive multiple sclerosis: a magnetic resonance spectroscopic imaging study.
Journal of Neurology
, 265
(8)
pp. 1795-1802.
10.1007/s00415-018-8903-y.
|
Melendez-Torres, GJ;
Armoiry, X;
Court, R;
Patterson, J;
Kan, A;
Auguste, P;
Madan, J;
... Clarke, A; + view all
(2018)
Comparative effectiveness of beta-interferons and glatiramer acetate for relapsing-remitting multiple sclerosis: systematic review and network meta-analysis of trials including recommended dosages.
BMC Neurology
, 18
, Article 162. 10.1186/s12883-018-1162-9.
|
Miller, DH;
Lublin, FD;
Sormani, MP;
Kappos, L;
Yaldizli, Ö;
Freedman, MS;
Cree, BAC;
... Wolinsky, JS; + view all
(2018)
Brain atrophy and disability worsening in primary progressive multiple sclerosis: Insights from the INFORMS study.
Annals of Clinical and Translational Neurology
, 5
(3)
pp. 346-356.
10.1002/acn3.534.
|
Monteverdi, A;
Solanky, B;
De Angelis, F;
Plantone, D;
Stutters, J;
John, N;
Casiraghi, L;
... MS-SMART trialists; + view all
(2018)
Exploring metabolite profiling of patients with secondary progressive multiple sclerosis.
Presented at: ISMRM 2018, Paris, France.
|
P
Palesi, F;
CALAMANTE, F;
Savini, G;
D'Angelo, E;
Wheeler-Kingshott, CAM;
(2018)
The unresolved problem of synaptic connectivity in the context of the cerebro-cerebellar loop.
Presented at: ISMRM 2018, Paris, France.
|
Palesi, F;
De Rinaldis, A;
Vitali, P;
Castellazzi, G;
Casiraghi, L;
Germani, G;
Bernini, S;
... Micieli, G; + view all
(2018)
Specific patterns of white matter alterations help distinguishing Alzheimer's and vascular dementia.
Frontiers in Neuroscience
, 12
, Article 274. 10.3389/fnins.2018.00274.
|
Phyu, P;
Merwick, A;
Davagnanam, I;
Bolsover, F;
Jichi, F;
Wheeler-Kingshott, C;
Golay, X;
... Werring, DJ; + view all
(2018)
Increased resting cerebral blood flow in adult Fabry disease: MRI arterial spin labeling study.
Neurology
, 90
(16)
e1379-e1385.
10.1212/WNL.0000000000005330.
|
Piers, TM;
East, E;
Villegas-Llerena, C;
Sevastou, IG;
Matarin, M;
Hardy, J;
Pocock, JM;
(2018)
Soluble Fibrinogen Triggers Non-cell Autonomous ER Stress-Mediated Microglial-Induced Neurotoxicity.
Frontiers in Cellular Neuroscience
, 12
, Article 404. 10.3389/fncel.2018.00404.
|
Pocock, JM;
Piers, TM;
(2018)
Modelling microglial function with induced pluripotent stem cells: an update.
Nature Reviews Neuroscience
, 19
pp. 445-452.
10.1038/s41583-018-0030-3.
|
Powell, E;
Prados Carrasco, F;
Brownlee, W;
Kanber, B;
Collorone, S;
Ourselin, S;
Ciccarelli, O;
... Wheeler-Kingshott, CAM; + view all
(2018)
A comparison of subnetwork classification methods.
Presented at: ISMRM 2018, Paris, France.
|
R
Rahn, AC;
Köpke, S;
Stellmann, J-P;
Schiffmann, I;
Lukas, C;
Chard, D;
Heesen, C;
(2018)
Magnetic resonance imaging as a prognostic disability marker in clinically isolated syndrome: A systematic review.
[Review].
Acta Neurol Scand
10.1111/ane.13010.
(In press).
|
Ricciardi, A;
Grussu, F;
Brownlee, W;
Kanber, B;
Prados Carrasco, F;
Collorone, S;
Kaden, E;
... Wheeler-Kingshott, CAM; + view all
(2018)
Biophysically meaningful MRI features for accurate classification of multiple sclerosis phenotypes.
Presented at: ISMRM 2018, Paris, France.
|
Ricciardi, A;
Grussu, F;
Samson, R;
Alexander, DC;
Wheeler-Kingshott, CAM;
(2018)
Reconstruction of quantitative proton density maps from routine clinical data.
Presented at: ISMRM 2018, Paris, France.
|
Riemer, F;
Solanky, BS;
Wheeler-Kingshott, CAM;
Golay, X;
(2018)
Bi‐exponential 23Na T2* component analysis in the human brain.
NMR in Biomedicine
, 31
(5)
10.1002/nbm.3899.
|
Rio, J;
Rovira, A;
Tintore, M;
Otero-Romero, S;
Comabella, M;
Vidal-Jordana, A;
Galan, I;
... Montalban, X; + view all
(2018)
Disability progression markers over 6-12 years in interferon-beta-treated multiple sclerosis patients.
Multiple Sclerosis Journal
, 24
(3)
pp. 322-330.
10.1177/1352458517698052.
|
Rocca, MA;
Barkhof, F;
De Luca, J;
Frisen, J;
Geurts, JJG;
Hulst, HE;
Sastre-Garriga, J;
... MAGNIMS Study Group, .; + view all
(2018)
The hippocampus in multiple sclerosis.
The Lancet Neurology
, 17
(10)
pp. 918-926.
10.1016/S1474-4422(18)30309-0.
|
S
Sa, M;
Hacohen, Y;
Alderson, L;
Chong, WKK;
Anderson, G;
Jacques, TS;
Neubauer, D;
... Kaliakatsos, M; + view all
(2018)
Immunotherapy-responsive childhood neurodegeneration with systemic and central nervous system inflammation.
European Journal of Paediatric Neurology
, 22
(5)
pp. 882-888.
10.1016/j.ejpn.2018.04.010.
|
Sajic, M;
Ida, KK;
Canning, R;
Gregson, NA;
Duchen, MR;
Smith, KJ;
(2018)
Mitochondrial damage and "plugging" of transport selectively in myelinated, small-diameter axons are major early events in peripheral neuroinflammation.
Journal of Neuroinflammation
, 15
, Article 61. 10.1186/s12974-018-1094-8.
|
Samson, R;
Battiston, M;
Seif, M;
Cohen-Adad, J;
Freund, P;
Gandini Wheeler-Kingshott, C;
(2018)
Comparison of cervical cord results from a quantitative 3D multi-parameter mapping (MPM) protocol of the whole brain with a dedicated cervical cord protocol.
In:
Proceedings of the Joint Annual Meeting ISMRM-ESMRMB 2018.
International Society for Magnetic Resonance in Medicine (ISMRM)
|
Samson, R;
Stephanie, A;
Gilbert, G;
Gandini Wheeler-Kingshott, CAM;
Grussu, F;
Martin, A;
Bannier, E;
... Cohen-Adad, J; + view all
(2018)
Consensus acquisition protocol for quantitative MRI of the cervical spinal cord at 3T.
In:
Proceedings of the Joint Annual Meeting ISMRM-ESMRMB 2018.
International Society for Magnetic Resonance in Medicine (ISMRM)
|
Schoonheim, MM;
Ciccarelli, O;
(2018)
The value of including thalamic atrophy as a clinical trial endpoint in multiple sclerosis.
[Editorial comment].
Neurology
, 90
(15)
pp. 677-678.
10.1212/WNL.0000000000005279.
|
Scott, G;
Zetterberg, H;
Jolly, A;
Cole, JH;
De Simoni, S;
Jenkins, PO;
Feeney, C;
... Sharp, DJ; + view all
(2018)
Minocycline reduces chronic microglial activation after brain trauma but increases neurodegeneration.
Brain
, 141
pp. 459-471.
10.1093/brain/awx339.
|
Seif, M;
Leutritz, T;
Samson, R;
Curt, A;
Wheeler-Kingshott, CAM;
Freund, P;
Weiskopf, N;
(2018)
A multi-center study on fast full-brain quantitative multi-parameter mapping of R1, MT, and R2*: scan-rescan repeatability and inter-site reproducibility.
In:
Proceedings of the Joint Annual Meeting ISMRM-ESMRMB 2018.
(pp. p. 1198).
International Society for Magnetic Resonance in Medicine (ISMRM): Paris, France.
|
Smerbeck, A;
Benedict, RHB;
Eshaghi, A;
Vanotti, S;
Spedo, C;
Blahova Dusankova, J;
Sahraian, MA;
... Langdon, D; + view all
(2018)
Influence of nationality on the Brief International Cognitive Assessment for Multiple Sclerosis (BICAMS).
The Clinical Neuropsychologist
, 32
(1)
pp. 54-62.
10.1080/13854046.2017.1354071.
|
Solanky, B;
Prados Carrasco, F;
Yiannakas, MC;
Bassan, V;
Kanber, B;
Ourselin, S;
Ciccarelli, O;
(2018)
Associations between tissue sodium concentration, age and cross-sectional area in the healthy spinal cord.
Presented at: ISMRM 2018, Paris, France.
|
Sudre, CH;
Prados Carrasco, F;
Cortese, R;
Yiannakas, M;
Kearney, H;
Ciccarelli, O;
Ourselin, S;
... Cardoso, M; + view all
(2018)
A fully unsupervised method for spinal cord lesion segmentationin multiple sclerosis.
Presented at: ISMRM 2018, Paris, France.
|
Summers, P;
Palesi, F;
Zucca, I;
malagoli, M;
Maccagnano, C;
Meletti, S;
Didato, G;
... Vitali, P; + view all
(2018)
Setting up a multi-centric multiparametric hMRI protocol for the investigation of temporal lobe epilepsy.
Presented at: ISMRM 2018, Paris, France.
|
T
Thompson, AJ;
Baranzini, SE;
Geurts, J;
Hemmer, B;
Ciccarelli, O;
(2018)
Multiple sclerosis.
The Lancet
, 391
(10130)
pp. 1622-1636.
10.1016/S0140-6736(18)30481-1.
|
Thust, SC;
Hassanein, S;
Bisdas, S;
Rees, JH;
Hyare, H;
Maynard, JA;
Brandner, S;
... Mancini, L; + view all
(2018)
Apparent diffusion coefficient for molecular subtyping of non-gadolinium-enhancing WHO grade II/III glioma: volumetric segmentation versus two-dimensional region of interest analysis.
European Radiology
, 28
(9)
pp. 3779-3788.
10.1007/s00330-018-5351-0.
|
Toosy, AT;
(2018)
Valuable Insights Into Visual Neuroplasticity After Optic Neuritis.
JAMA Neurology
, 75
(3)
pp. 274-276.
10.1001/jamaneurol.2017.3065.
|
Tourbah, A;
Gout, O;
Vighetto, A;
Deburghgraeve, V;
Pelletier, J;
Papeix, C;
Lebrun-Frenay, C;
... Arndt, C; + view all
(2018)
MD1003 (High-Dose Pharmaceutical-Grade Biotin) for the Treatment of Chronic Visual Loss Related to Optic Neuritis in Multiple Sclerosis: A Randomized, Double-Blind, Placebo-Controlled Study.
CNS Drugs
, 32
(7)
pp. 661-672.
10.1007/s40263-018-0528-2.
|
Tur, C;
Eshaghi, A;
Altmann, DR;
Jenkins, TM;
Prados, F;
Grussu, F;
Charalambous, T;
... Toosy, AT; + view all
(2018)
Structural cortical network reorganization associated with early conversion to multiple sclerosis.
Scientific Reports
, 8
, Article 10715. 10.1038/s41598-018-29017-1.
|
Tur, C;
Marschallinger, R;
Prados, F;
Collorone, S;
Altmann, DR;
Ourselin, S;
Wheeler-Kingshott, CAM;
(2018)
Linking macrostructural and microstructural damage in early MS: a geostatistical and diffusion MRI study.
In:
Proceedings of the Joint Annual Meeting ISMRM-ESMRMB 2018.
(pp. 0090).
ISMRM: Paris, France.
|
Tur, C;
Moccia, M;
Barkhof, F;
Chataway, J;
Sastre-Garriga, J;
Thompson, AJ;
Ciccarelli, O;
(2018)
Assessing treatment outcomes in multiple sclerosis trials and in the clinical setting.
Nature Reviews Neurology
, 14
pp. 75-93.
10.1038/nrneurol.2017.171.
|
V
Varley, JA;
Webb, AJS;
Balint, B;
Fung, VSC;
Sethi, KD;
Tijssen, MAJ;
Lynch, T;
... Irani, SR; + view all
(2018)
The Movement disorder associated with NMDAR antibody-encephalitis is complex and characteristic: an expert video-rating study.
J Neurol Neurosurg Psychiatry
10.1136/jnnp-2018-318584.
(In press).
|
Vidal-Jordana, A;
Sastre-Garriga, J;
Pareto, D;
Tur, C;
Arrambide, G;
Otero-Romero, S;
Huerga, E;
... Montalban, X; + view all
(2018)
Brain atrophy 15 years after CIS: Baseline and follow-up clinico-radiological correlations.
Multiple Sclerosis Journal
, 24
(6)
pp. 721-727.
10.1177/1352458517707070.
|
W
Wells, E;
Hacohen, Y;
Waldman, A;
Tillema, JM;
Soldatos, A;
Ances, B;
Benseler, S;
... Banwell, B; + view all
(2018)
Neuroimmune disorders of the central nervous system in children in the molecular era.
Nature Reviews Neurology
, 14
pp. 433-445.
10.1038/s41582-018-0024-9.
|
Wheeler-Kingshott, CAM;
Riemer, F;
Palesi, F;
Ricciardi, A;
Castellazzi, G;
Golay, X;
Prados Carrasco, F;
... D'Angelo, EU; + view all
(2018)
Challenges and perspectives of quantitative functional sodium imaging (fNaI).
Frontiers in Neuroscience
, 12
, Article 810. 10.3389/fnins.2018.00810.
|
Williams, T;
Donnelly, A;
Enriquez-Larrondo, M;
Brownlee, WJ;
Chataway, J;
(2018)
Disease activity and lymphocyte dynamics in patients switching to alemtuzumab from fingolimod.
Presented at: 34th Congress of the European Committee for Treatment and Research of Multiple Sclerosis (ECTRIMS 2018), Berlin, Germany.
|
Wong, YYM;
Hacohen, Y;
Armangue, T;
Wassmer, E;
Verhelst, H;
Hemingway, C;
van Pelt, ED;
... Neuteboom, RF; + view all
(2018)
Paediatric acute disseminated encephalomyelitis followed by optic neuritis: disease course, treatment response and outcome.
European Journal of Neurology
, 25
(5)
pp. 782-786.
10.1111/ene.13602.
|
X
Xiang, X;
Piers, TM;
Wefers, B;
Zhu, K;
Mallach, A;
Brunner, B;
Kleinberger, G;
... Haass, C; + view all
(2018)
The Trem2 R47H Alzheimer's risk variant impairs splicing and reduces Trem2 mRNA and protein in mice but not in humans.
Molecular Neurodegeneration
, 13
(1)
, Article 49. 10.1186/s13024-018-0280-6.
|
Y
Yaldizli, Ö;
Sethi, V;
Pardini, M;
Tur, C;
Mok, KY;
Muhlert, N;
Liu, Z;
... Chard, DT; + view all
(2018)
Response to the commentary of Yates RL and DeLuca GC on the study: HLA-DRB1*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.
Multiple Sclerosis and Related Disorders
, 19
pp. 168-170.
10.1016/j.msard.2016.08.006.
|
Yi, JH;
Kim, DH;
Piers, TM;
Kim, SC;
Whitcomb, DJ;
Regan, P;
Cho, K;
(2018)
Postsynaptic p47phox regulates long-term depression in the hippocampus.
Cell Discovery
, 4
, Article 44. 10.1038/s41421-018-0046-x.
|